New Preeclampsia Research Funded to Investigate Genetic Targets to Develop Potential Therapeutics
Research Funding Available for Preeclampsia and Related Pregnancy Disorders
Preeclampsia Foundation Canada has announced that Kylie Belchamber, PhD of University of Birmingham, and Serena Gundy, MD, FRCP of McMaster University, are their 2023 Vision Grant research award recipients. These highly competitive monetary awards re...
New preeclampsia research funded by Preeclampsia Foundation Peter J. Pappas grant finds distinct genetic traits of early-onset preeclampsia.
A recent meta-analysis of 130 preeclampsia prevention trials found some successful strategies but demonstrated the need for more research.
Self-monitoring of blood pressure outside the doctor’s office may help identify women with masked hypertension during pregnancy.
Research study suggests that planned delivery at term (37 weeks) may be an intervention worthy of consideration in women at high-risk for preeclampsia.
This study looked at whether a genome wide analysis study could identify and use maternal DNA variation to predict preeclampsia and gestational hypertension.
This study looked at whether messenger RNA markers in the blood stream could help identify patients at risk of developing preterm or early-onset preeclampsia.
Peter Joseph Pappas preeclampsia research grant recipients' study titles and reports.
The Preeclampsia Foundation is seeking Letters of Intent for the Peter Joseph Pappas Research Grants funding program, designed to accelerate preeclampsia research for two, two-year grants of up to $200,000.
A new diagnostic test for preeclampsia has received approval from the US Food and Drug Administration for use in hospital settings.